[Prevalence of arterial XXXX and its treatment in 2,595 adults].

@entity1 @entity7031 @entity101 @entity301
The prevalence of arterial @entity101 , as defined by the W.H.O. (systolic BP greater than 160 mmHg and/or diastolic BP greater than 95 mmHg), and the prevalence of its treatment were studied in 2595 local government employees of Marseilles, aged from 20 to 65 years. The prevalence of @entity101 was 17.96 p. 100 (466/2595, including 222 @entity1 and 244 @entity1 ). The prevalence of normal tension was 57.50 p. 100 (1492/2595, including 802 @entity1 and 690 @entity1 ). The prevalence of treated @entity101 was 37.98 p. 100 (177/466) divided into 29.27 p. 100 (65/222) in @entity1 and 45.90 p. 100 (112/244) in @entity1 (p less than 0.0001). Blood pressure was controlled by treatment in 32.30 p. 100 (21/65) of treated @entity1 and in 36.61 p. 100 (41/112) of treated @entity1 ( @entity7031 ). 81.14 p. 100 (198/244) of @entity101 @entity1 and 57/82 p. 100 (399/690) of normotensive @entity1 were active (managers, executives). In treated @entity1 , the plasma level of apoprotein A1 was decreased and that of apoprotein B was increased. Among @entity1 , the global score at Bortner questionnaire was significantly lower in the group of 175 untreated @entity101 @entity1 (176 +/- 46) than in the group of treated @entity101 @entity1 (192 +/- 48, p less than 0.05) and in the group of normotensive subjects (186 +/- 41, p less than 0.05). This indicated that untreated @entity101 @entity1 have a tendency to type B pattern and suggested a line of research aimed at a better understanding of the relative failure of anti- @entity101 treatments in the prevention of @entity301 .
